These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8799643)

  • 1. Decrease in mortality from diabetic nephropathy in Pima Indians.
    Bell DS
    Diabetes Care; 1996 Jul; 19(7):779. PubMed ID: 8799643
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic nephropathy in American Indians, with a special emphasis on the Pima Indians.
    Pavkov ME; Knowler WC; Hanson RL; Nelson RG
    Curr Diab Rep; 2008 Dec; 8(6):486-93. PubMed ID: 18990306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should all Pima Indians with type 2 diabetes mellitus be prescribed routine angiotensin-converting enzyme inhibition therapy to prevent renal failure?
    Kiberd BA; Jindal KK
    Mayo Clin Proc; 1999 Jun; 74(6):559-64. PubMed ID: 10377929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential trends in overall and cause-specific mortality in diabetic and nondiabetic Pima Indians.
    Sievers ML; Nelson RG; Bennett PH
    Diabetes Care; 1996 Feb; 19(2):107-11. PubMed ID: 8718428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma leptin concentrations: no difference between diabetic Pima Indians with and without nephropathy.
    Wilson C; Nelson R; Nicolson M; Pratley R
    Diabetologia; 1998 Jul; 41(7):861-2. PubMed ID: 9686932
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics of diabetic nephropathy in the Pima Indians.
    Imperatore G; Knowler WC; Nelson RG; Hanson RL
    Curr Diab Rep; 2001 Dec; 1(3):275-81. PubMed ID: 12643210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing course of diabetic nephropathy in the Pima Indians.
    Nelson RG; Pavkov ME; Hanson RL; Knowler WC
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1(Suppl 1):S10-4. PubMed ID: 18842316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical and histologic study of diabetic nephropathy in the Pima Indians.
    Kamenetzky SA; Bennett PH; Dippe SE; Miller M; LeCompte PM
    Diabetes; 1974 Jan; 23(1):61-8. PubMed ID: 4809621
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
    Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
    JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in mortality from diabetic nephropathy in Pima Indians.
    Sievers ML; Nelson RG; Bennett PH
    Diabetes Care; 1996 Jul; 19(7):777. PubMed ID: 8799640
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of NIDDM on mortality and causes of death in Pima Indians.
    Sievers ML; Nelson RG; Knowler WC; Bennett PH
    Diabetes Care; 1992 Nov; 15(11):1541-9. PubMed ID: 1468284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic kidney disease in Pima Indians.
    Nelson RG; Knowler WC; Pettitt DJ; Saad MF; Bennett PH
    Diabetes Care; 1993 Jan; 16(1):335-41. PubMed ID: 8422805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival during renal replacement therapy for diabetic end-stage renal disease in Pima Indians.
    Nelson RG; Hanson RL; Pettitt DJ; Knowler WC; Bennett PH
    Diabetes Care; 1996 Dec; 19(12):1333-7. PubMed ID: 8941459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A basis for accelerated progression of diabetic nephropathy in Pima Indians.
    Lemley KV
    Kidney Int Suppl; 2003 Feb; (83):S38-42. PubMed ID: 12864873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic renal disease in Pima Indians.
    Nelson RG; Bennett PH
    Transplant Proc; 1989 Dec; 21(6):3913-5. PubMed ID: 2609404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group.
    Imperatore G; Hanson RL; Pettitt DJ; Kobes S; Bennett PH; Knowler WC
    Diabetes; 1998 May; 47(5):821-30. PubMed ID: 9588456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do ACE inhibitors affect diabetic morbidity and mortality?
    Brungardt GS
    Ann Intern Med; 1993 Oct; 119(8):860-1. PubMed ID: 8379611
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diabetic nephropathy and ACE inhibitors].
    Amann B
    Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i83-7. PubMed ID: 16598556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibition in diabetic nephropathy. The Collaborative Study Group.
    Breyer JA; Hunsicker LG; Bain RP; Lewis EJ
    Kidney Int Suppl; 1994 Feb; 45():S156-60. PubMed ID: 8158886
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review.
    Strippoli GF; Craig M; Deeks JJ; Schena FP; Craig JC
    BMJ; 2004 Oct; 329(7470):828. PubMed ID: 15459003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.